Login to Your Account

Integrilin Boosts Profitability Push

Use Of Velcade Widening As Various Trials March On

By Randall Osborne

Monday, November 22, 2004
When Millennium Pharmaceuticals Inc. nailed down its overseas marketing deal in July 2003 with Ortho Biotech Products LP for the multiple myeloma drug Velcade (approved two months earlier), investors sat up and took notice. (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription